secwatch.observer — SEC 8-K summary
======================================

Issuer:     IN8BIO, INC. (INAB)
CIK:        0001740279
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001193125-25-134487
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IN8bio to effect 1-for-30 reverse stock split effective June 5, 2025
--------------------------------------------------------------------

- Reverse split at 1-for-30 ratio; effective 5:00 p.m. ET on June 5, 2025.
- Shares outstanding will reduce from ~103.3M to ~3.4M (subject to fractional share cash-out).
- Stock begins trading on Nasdaq on split-adjusted basis June 6, 2025; new CUSIP 45674E208.
- Proportionate adjustments to stock options, warrants, and equity plan reserves; no fractional shares issued.
- Charter Amendment filed as Exhibit 3.1; authorized by stockholders on May 8, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740279/000119312525134487/0001193125-25-134487-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740279/000119312525134487/d927529d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-134487

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer